Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
AMHR2 encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. Additionally we are shipping AMHR2 Proteins (11) and AMHR2 Kits (4) and many more products for this protein.
Showing 10 out of 67 products:
Human Polyclonal AMHR2 Primary Antibody for WB - ABIN391173
Visser, McLuskey, van Beers, Weghuis, van Kessel, Grootegoed, Themmen: Structure and chromosomal localization of the human anti-müllerian hormone type II receptor gene. in Biochemical and biophysical research communications 1995
Show all 4 references for ABIN391173
Human Polyclonal AMHR2 Primary Antibody for EIA, WB - ABIN359242
Teixeira, Maheswaran, Donahoe: Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. in Endocrine reviews 2001
Show all 4 references for ABIN359242
Human Polyclonal AMHR2 Primary Antibody for EIA, WB - ABIN359241
Picard, Belville: [Genetics and molecular pathology of anti-Mullerian hormone and its receptor]. in Journal de la Société de biologie 2002
Show all 2 references for ABIN359241
Human Polyclonal AMHR2 Primary Antibody for FACS, WB - ABIN391175
Carrarelli, Rocha, Belmonte, Zupi, Abrão, Arcuri, Piomboni, Petraglia: Increased expression of antimüllerian hormone and its receptor in endometriosis. in Fertility and sterility 2014
Show all 2 references for ABIN391175
These findings indicate the followings: AMH (show AMH Antibodies) mRNA levels decrease in both dominant and secondary follicles during follicular deviation; granulosa cells from heathy follicles express more AMH (show AMH Antibodies) mRNA compared to subordinate follicles undergoing atresia and FSH (show BRD2 Antibodies) stimulates AMH (show AMH Antibodies) and AMHR2 mRNA expression in granulosa cells of co-dominant follicles.
Sertoli cell maturation during puberty in the stallion was accompanied by a reduced expression of anti-Mullerian hormone (show AMH Antibodies) and its receptor, arrest of cell proliferation, increased expression of androgen receptor (show AR Antibodies)
a result of VEGF (show VEGFA Antibodies) misregulation, AMHR2 overexpression increases AMH (show AMH Antibodies) binding, which may attenuate follicular or oocyte maturation.
Neither AMH (show AMH Antibodies) nor AMHR2 polymorphisms were related to age, BMI, hormone levels or ovarian parameters in the follicular phase in women of late reproductive stage.
There is no association between single nucleotide polymorphisms in the AMH/AMHR2 signaling pathway and early ovarian hyperstimulation syndrome in Han Chinese women
A significant subset of GnRH neurons express the AMH receptor.
A significant portion of AMHRII was missing most of its extracellular domain (ECD (show SHFM1 Antibodies)) and was unfolded and retained in the endoplasmic reticulum.
study demonstrated for the first time that human placenta and fetal membranes express and co-localize Anti-Mullerian hormone(AMH (show AMH Antibodies)) and Anti-Mullerian hormone (show AMH Antibodies) Receptor (show NR4A1 Antibodies) II
AMHR2 rs11170555 and rs3741664 were positively associated with AMH (show AMH Antibodies), estradiol and FSH (show BRD2 Antibodies) levels.
There was evidence that in specific subgroups of women undergoing IVF (show SCN5A Antibodies)/ICSI, AMH (show AMH Antibodies) and AMHRII SNPs may be related to patients' characteristics and controlled ovarian stimulation and pregnancy outcome
These findings suggest that patients with primary ovarian insufficiency in China share AMH (show AMH Antibodies) and AMHR2 genetic variants with those who go through menopause at a normal age.
Data indicate that Muellerian inhibiting substance (show AMH Antibodies) type II receptor (MISRII) is a promising target for the control of ovarian granulosa cell tumors (GCT (show QPCT Antibodies)) and epithelial ovarian cancers (EOC).
A significant subset of GnRH neurons express the AMH receptor and AMH potently activates the GnRH neuron firing.
physiological function(s) of type 2 anti-Mullerian hormone (show AMH Antibodies) receptor (show NR4A1 Antibodies)
Wt1 (show WT1 Antibodies) is an activator of Amhr2.
This gene encodes the receptor for the anti-Mullerian hormone (AMH) which, in addition to testosterone, results in male sex differentiation. AMH and testosterone are produced in the testes by different cells and have different effects. Testosterone promotes the development of male genitalia while the binding of AMH to the encoded receptor prevents the development of the mullerian ducts into uterus and Fallopian tubes. Mutations in this gene are associated with persistent Mullerian duct syndrome type II. Alternatively spliced transcript variants encoding different isoforms have been identified.
anti-Muellerian hormone type-2 receptor
, Anti-Muellerian hormone type-2 receptor
, anti-Mullerian hormone receptor, type II
, anti-Muellerian hormone type-2 receptor-like
, AMH type II receptor
, MIS type II receptor
, Muellerian inhibiting substance type II receptor
, Mullerian inhibiting substance type II receptor
, anti-Muellerian hormone type II receptor
, anti-Mullerian hormone type 2 receptor